SOURCE: ML Capital Group Inc.

February 26, 2014 09:15 ET

ML Capital Group, Inc. Expands Its Business in the Medical Marijuana Industry With SuperStar Vapor Pens

FOUNTAIN HILLS, AZ--(Marketwired - Feb 26, 2014) - ML Capital Group, Inc. (OTCQB: MLCG) is proud to announce that it is expanding its business in the medical marijuana industry to also include vapor pens. 

ML Capital Group, Inc. ("MLCG" or the "Company") previously announced its entry into the medical marijuana industry with the development of smart phone applications that connect people with an array of resources that support their needs. Recently, the Company found another profitable market to pursue with vapor pens, and has trademarked the brand "SuperStar Vapor Pens."

The Company has embarked upon an aggressive sales campaign to launch this new product line during the next two months and has initiated a commercial order with an international manufacturer of specialized and customized vapor pens to be shipped here in the coming weeks. Furthermore, the Company has already received verbal commitments with two major distributors to carry SuperStar Vapor Pens and sell them on a national level and anticipates finalizing a formal purchase contract within the next ten days. In addition, with MLCG commercializing its vapor pen product line -- it solidifies the Company's strategy as a safe play within the industry as it will not handle, grow, distribute, or touch medical marijuana.

The benefits of medical marijuana continue to rise as industry related research becomes published and more scientific institutions embrace green medicine as an effective remedy to some of the world's most common ailments. Recent studies have found that marijuana can be an effective treatment for sleep disorders such as insomnia and sleep apnea, which affect millions of people world-wide. In fact, a team of researchers led by Dr. David W. Carley published the first human study on medical marijuana compounds and sleep apnea earlier this year and subsequently received a $5 million grant from the NIH to investigate their findings further. An interesting highlight to note is that the sleep disorder industry is a $32.4 Billion business in the U.S. alone. 

Mrs. Lisa Nelson, the Company's President and CEO, commented, "Medical marijuana is an amazing high growth industry that we truly believe helps people in so many ways. Expanding our business into vapor pens will help us to further entrench ourselves in the market and gives us the opportunity to quickly launch our product line. This is the beginning of something very big with one of the most dynamic industries in the world, and we're very excited about the upcoming commercial release of our SuperStar Vapor Pens brand to the market."

About ML Capital Group, Inc.:

ML Capital Group, Inc.'s primary business consists of providing management, financial and strategic consulting services designed to advance and improve an organization's ability to conduct its business more effectively and to foster sales growth, with a principal focus on assisting companies in the green technology industry. With this press release, the Company continues to expand into the "Green Medicine" or medical marijuana industry as it adds another product line to its business.

ML Capital Group's stock is traded on the OTC Bulletin Board and OTC Markets where it is qualified to be listed in the QB marketplace as a current reporting company. You can access the Company's stock quote directly from OTC Markets at To find out more information on the Company, visit its website at

Safe Harbor Statement:

This update includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. 

Contact Information

  • Investor Relations Contact:

    Lisa Nelson
    President & CEO
    ML Capital Group, Inc.
    Phone: 480-816-5308